INSURERS: Requires health insurers to cover proton therapy for cancer patients. (8/1/25) (EN NO IMPACT See Note)
SB 129 requires health insurance companies to cover proton therapy for cancer treatment when recommended by the American Society for Radiation Oncology guidelines. This directly affects cancer patients seeking this specialized treatment and health insurers who must provide coverage without denial. The bill prohibits insurers from refusing coverage for proton therapy under these specific clinical guidelines. It does not change existing coverage rules for other treatments or impose new financial burdens on the state, as noted in the bill's "EN NO IMPACT" designation.
Bill status
signed
all 5 stages cleared
Introduction
Apr 2025
Committee Review
May 2025
Senate Passage
Jun 2025
House Passage
Jun 2025
Signed into Law
Jun 2025
Introduced Apr 4, 2025
Signed Jun 8, 2025
Maddy AI version diff · 3 comparisons
What changed between versions
SB129 Original
→
SB129 Act
·
4 edits
MODERATE
This bill updates the law to require health insurers to cover proton beam therapy for cancer patients when recommended by the American Society for Radiation Oncology. It also clarifies that coverage rules do not apply to short-term policies under twelve months or specific limited benefit plans. The effective date for new policies is set for January 1, 2026, with existing policies required to convert to the new standards by January 1, 2027.
Scope change
The bill's scope was expanded to include Representative Chassion as a sponsor and the coverage requirement was refined to specifically reference American Society for Radiation Oncology guidelines. Additionally, the applicability was clarified to explicitly exclude short-term policies and limited health benefit plans.
ELIGIBILITY
The requirement for coverage now specifically mandates that proton therapy be recommended by the American Society for Radiation Oncology practice guidelines.
REQUIREMENT
Added a new provision explicitly stating that the coverage requirements do not apply to plans providing coverage for excepted benefits, limited health benefit insurance plans, or short-term policies with a term of less than twelve months.
TIMELINE
Extended the deadline for existing policies to convert to the new provisions from January 1, 2026, to January 1, 2027.
TECHNICAL
Added Representative Chassion as a co-sponsor to the bill.
Floor votes · Senate May 7, 2025 · House Jun 2, 2025
How they voted
33–0
Passed · 4 other
Total votes 37
May 7, 2025
D
Democratic11
72% Yea
R
Republican26
96% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
21
Key actions
6
Committee
6
Amendments
1
Jun 3, 2025
Upper · Passed
Amendments proposed by the House read and concurred in by a vote of 37 yeas and 0 nays.
upper
Jun 2, 2025
Lower · Passed
Read third time by title, roll called on final passage, yeas 97, nays 2. Finally passed, ordered to the Senate.
lower
May 22, 2025
Introduced
Reported without Legislative Bureau amendments.
lower
May 21, 2025
Lower · Passed
Reported with amendments (11-0). Referred to the Legislative Bureau.
lower
May 8, 2025
Committee
Read by title, under the rules, referred to the Committee on Insurance.
lower
May 7, 2025
Upper · Passed
Read by title, passed by a vote of 35 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.
upper
May 5, 2025
Upper · Passed
Rules suspended. Recalled from Committee.
upper
Apr 28, 2025
Committee
Read by title. Committee amendments read and adopted; ordered engrossed and recommitted to the Committee on Finance.
upper
Apr 23, 2025
Upper · Passed
Reported with amendments.
upper
Apr 14, 2025
Committee
Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 129
Scope: LA
Hi! I can help you understand SB 129. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline